Australian Pharmaceutical Industries Revenue and Competitors

AU

Location

N/A

Total Funding

Retail

Industry

Estimated Revenue & Valuation

  • Australian Pharmaceutical Industries's estimated annual revenue is currently $232.3M per year.(i)
  • Australian Pharmaceutical Industries's estimated revenue per employee is $317,800

Employee Data

  • Australian Pharmaceutical Industries has 731 Employees.(i)
  • Australian Pharmaceutical Industries grew their employee count by -8% last year.

Australian Pharmaceutical Industries's People

NameTitleEmail/Phone
1
Head Supply Chain ServicesReveal Email/Phone
2
Head Business Enablement & InnovationReveal Email/Phone
3
Safety OfficerReveal Email/Phone
4
Head Service DeliveryReveal Email/Phone
5
Credit OfficerReveal Email/Phone
6
Head Quality and Regulatory Affairs - Consumer Brands - AustraliaReveal Email/Phone
7
Compliance Officer and AdministrationReveal Email/Phone
8
Site Safety OfficerReveal Email/Phone
9
IT Project ManagerReveal Email/Phone
10
Information Technology Project ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$12.3M60N/AN/AN/A
#2
$6.7M37N/AN/AN/A
#3
$18.4M817%N/AN/A
#4
$27.7M12227%N/AN/A
#5
$24.5M1087%N/AN/A
#6
$60.4M2427%N/AN/A
#7
$65.7M263N/AN/AN/A
#8
$24.5M1086%N/AN/A
#9
$6.7M37-36%N/AN/A
#10
$58.4M234-7%N/AN/A
Add Company

What Is Australian Pharmaceutical Industries?

Australian Pharmaceutical Industries (API) is one of Australia's leading health and beauty companies. API has a number of brands and banners in the retail health and beauty industry, including Priceline, Soul Pattinson and Pharmacist Advice. API is one of the leading service providers to the pharmacy industry in Australia and today has a relationship with more than 4000 independent pharmacies. The services include wholesale product delivery, retail services, marketing programs and business advisory services. API also owns and operates the Priceline retail store brand that is a leading health and beauty brand in Australia. The company has product manufacturing capabilities and it is a niche player in over-the-counter pharmaceuticals and toiletries, which supply the Australian and New Zealand markets.

keywords:N/A

N/A

Total Funding

731

Number of Employees

$232.3M

Revenue (est)

-8%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Australian Pharmaceutical Industries News

2022-04-17 - WES, GMG, WOW, TCL: A look at latest updates by these ASX shares

WFM Investments Pty Ltd, a wholly owned subsidiary of Wesfarmers, acquired 100% shares in Australian Pharmaceutical Industries.

2022-04-13 - Rulings and addenda issued

Class Ruling CR 2022/38 Australian Pharmaceutical Industries Ltd — scheme of arrangement, ordinary dividend and special dividend.

2022-03-30 - As it happened: Tumbling oil prices sends ASX lower, Wesfarmers completes API deal

A sell-off in tech drove ASX's losses, with the sector finishing the session ... the acquisition of Australian Pharmaceutical Industries,...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$184.5M7327%N/A
#2
$184.5M732N/AN/A
#3
$75M73223%N/A
#4
$102.6M73325%N/A
#5
$277.1M733-2%N/A